Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19692134rdf:typepubmed:Citationlld:pubmed
pubmed-article:19692134lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0038766lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0205169lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C0061323lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:19692134lifeskim:mentionsumls-concept:C2003521lld:lifeskim
pubmed-article:19692134pubmed:issue1lld:pubmed
pubmed-article:19692134pubmed:dateCreated2009-9-14lld:pubmed
pubmed-article:19692134pubmed:abstractTextThe aim of this study was to compare the effect of continuation or discontinuation of glimepiride upon starting insulin therapy in type 2 diabetic patients poorly controlled with sub-maximal glimepiride.lld:pubmed
pubmed-article:19692134pubmed:languageenglld:pubmed
pubmed-article:19692134pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19692134pubmed:citationSubsetIMlld:pubmed
pubmed-article:19692134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19692134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19692134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19692134pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19692134pubmed:statusMEDLINElld:pubmed
pubmed-article:19692134pubmed:monthOctlld:pubmed
pubmed-article:19692134pubmed:issn1872-8227lld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:ShimizuTTlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:ArakawaMMlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:HiroseTTlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:MitiLLlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:KawamoriRRlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:EbataMMlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:FujitaniYYlld:pubmed
pubmed-article:19692134pubmed:authorpubmed-author:WatadaHHlld:pubmed
pubmed-article:19692134pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19692134pubmed:volume86lld:pubmed
pubmed-article:19692134pubmed:ownerNLMlld:pubmed
pubmed-article:19692134pubmed:authorsCompleteYlld:pubmed
pubmed-article:19692134pubmed:pagination31-6lld:pubmed
pubmed-article:19692134pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:meshHeadingpubmed-meshheading:19692134...lld:pubmed
pubmed-article:19692134pubmed:year2009lld:pubmed
pubmed-article:19692134pubmed:articleTitleEffect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride.lld:pubmed
pubmed-article:19692134pubmed:affiliationDepartment of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan.lld:pubmed
pubmed-article:19692134pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19692134pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19692134pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed